Immigration consultations

​UK pharmaceutical companies are deeply concerned about the impact that restricting their ability to recruit and/or transfer individuals from overseas sites to the UK would have on aspects of their business and on their staff, including UK employees. You can see our responses to the Migration Advisory Committee below:

• ABPI response to Migration Advisory Committee on economic migration to the UK (PDF, 255KB)
• ABPI response to UK Border Agency Consultation – Limits on non-EU economic migration (PDF, 271KB)
• Home Affairs Committee inquiry into the immigration cap (PDF, 33KB)